Cargando…
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study
Background: New technologies and therapies allow the possibility of a single-visit test and treat model for hepatitis C virus (HCV), addressing some of the barriers to care faced by people who inject drugs. Methods: The TEMPO Pilot Study was an interventional cohort study evaluating a single-visit t...
Autores principales: | Conway, Anna, Read, Phillip, Gilliver, Rosie, McNaughton, Tony, Valerio, Heather, Cunningham, Evan B., Henderson, Charles, Hadlow, Brett, Molloy, Katrina, Doab, Anna, Tillakeratne, Shane, Pepolim, Lucy, Harrod, Mary Ellen, Dore, Gregory J., Grebely, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696805/ https://www.ncbi.nlm.nih.gov/pubmed/36366561 http://dx.doi.org/10.3390/v14112463 |
Ejemplares similares
-
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO‐C): An open‐label, single‐arm, phase 4, multicentre trial
por: Grebely, Jason, et al.
Publicado: (2020) -
Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar
por: Nyein, Phyo Pyae, et al.
Publicado: (2023) -
The tempos of performance
por: Shalev, Nir, et al.
Publicado: (2019) -
Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
por: Grebely, Jason, et al.
Publicado: (2017) -
HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection
por: MacParland, Sonya A., et al.
Publicado: (2016)